Skip to content

Cooper Companies

US · COO #1402 by market cap Listed 1970
54.75 -1.68 -2.98%
Live - 5344 symbols - heartbeat 139s ago · 2026-10-08 06:48
Pre-market 54.07 -1.24%
After-hours 55.00 +0.46%
Overnight 54.57 -0.33%
Market cap
10.41B
P/B
1.25
EPS
1.87
Reader sentiment Are you bullish or bearish on COO?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership rose 2.5 percentage points.

Institutional ownership

Held by institutions
111.71% +2.51pp
Institutions
819 -3
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund87.58%
Hedge Fund14.47%
Public Company4.56%
Private Company1.55%
Government Pension Fund1.37%
Corporate Pension Plan0.84%
Individual/Insider0.64%
Sovereign Wealth Fund0.48%
VC/PE Fund0.33%

Top holders as of 2026-06-30

BlackRock 7.90% · 15.03M sh
Vanguard Capital Management, LLC 7.29% · 13.85M sh
T. Rowe Price Group, Inc. 6.84% · 13.01M sh
State Street Global Advisors 4.68% · 8.89M sh
Vanguard Portfolio Management, LLC 4.56% · 8.67M sh
Browning West LP 3.78% · 7.20M sh
UBS Asset Management 3.41% · 6.48M sh
Kayne Anderson Rudnick Investment Management, LLC 2.86% · 5.43M sh
Geode Capital Management, LLC 2.82% · 5.36M sh
Franklin Resources 2.68% · 5.10M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 43 buys · 6 sells

NameRoleStake
Robert Weiss Independent Chairperson 0.29%
Albert White Chief Executive Officer 0.13%
Daniel McBride Chief Operating Officer 0.09%
Holly Sheffield President of CooperSurgical, Inc. 0.02%
Colleen Jay Independent Director 0.02%
Lawrence Kurzius Independent Director 0.02%
Brian Andrews Chief Financial Officer 0.02%
Gerard Warner President of CooperVision, Inc. 0.01%
Walter Rosebrough Independent Director 0.01%
Teresa Madden Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-15 Lawrence Kurzius Independent Director Open Market Acquisition +10,000 $54.93
2026-09-13 Lawrence Kurzius Independent Director Open Market Acquisition +10,000 $53.92
2026-09-13 Walter Rosebrough Independent Director Open Market Acquisition +10,000 $54.11–54.29
2026-09-10 Paul Keel Independent Director Open Market Acquisition +4,701 $53.18
2026-06-30 Paul Keel Independent Director Other Derivative Acquisition +2,814 --
2026-03-31 Robert Weiss Independent Chairperson Other Derivative Acquisition +3,779 --
2026-03-31 Robert Weiss Independent Chairperson Derivative Exercise and Retained +3,654 --
2026-03-31 Teresa Madden Independent Director Other Derivative Acquisition +3,779 --
2026-03-31 Teresa Madden Independent Director Derivative Exercise and Retained +3,322 --
2026-03-31 Lawrence Kurzius Independent Director Other Derivative Acquisition +3,779 --
2026-03-31 Lawrence Kurzius Independent Director Derivative Exercise and Retained +3,322 --
2026-03-31 Cynthia Lucchese Independent Director Other Derivative Acquisition +3,779 --
2026-03-31 Cynthia Lucchese Independent Director Derivative Exercise and Retained +3,322 --
2026-03-31 Walter Rosebrough Independent Director Other Derivative Acquisition +3,779 --
2026-03-31 Walter Rosebrough Independent Director Derivative Exercise and Retained +832 --
2026-03-31 Colleen Jay Independent Director Other Derivative Acquisition +4,157 --
2026-03-31 Colleen Jay Independent Director Derivative Exercise and Retained +3,322 --
2026-03-31 Maria Rivas Independent Director Other Derivative Acquisition +3,779 --
2026-03-31 Maria Rivas Independent Director Derivative Exercise and Retained +3,322 --
2026-03-31 Barbara Carbone Independent Director Other Derivative Acquisition +3,779 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 06:48:45 · For reference only, not investment advice and not tailored to your situation.